LA JOLLA, Calif. -- Although their genetic underpinnings differ, Alzheimer's disease, Parkinson's disease and Huntington's disease are all characterized by the untimely death of brain cellsWhat triggers cell death in the brain? According to a new study published by researchers at Sanford-Burnham M

read more>>

ST. PAUL, Minn. -- A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosedThe research is published in the July 28, 2010, online issue of Neurology®, the medical journal of the American Academy of NeurologyUsin

read more>>

STANFORD, Calif. -- Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's diseaseThis discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' deat

read more>>

EAST LANSING, Mich. -- A Michigan State University researcher is working to uncover how a protein known as parkin may help nerve cells fight off damage from Parkinson's disease, a strategy that could lead to new therapies for the degenerative ailmentJohn Goudreau, an osteopathic physician and dire

read more>>

Vernalis plc (LSE: VER), a leading development stage pharmaceutical company with a broad pipeline of clinical and early stage programmes, today announced that the company and its partner, Biogen Idec (NASDAQ: BIIB), will continue its novel A2A receptor antagonist programme for Parkinson’s Ba

read more>>

A group of researchers from Universidad Carlos III de Madrid (UC3M) has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brainThe research pro

read more>>

Many of the symptoms of Parkinson disease can be alleviated with drugs that target dompamine, a chemical in the brain that is involved in nerve cell communication and therefore known as a neurotransmitterHowever, such drugs do not improve the gait disorders and falls that commonly affect individua

read more>>

A new study on vitamin D levels and Parkinson's disease risk points to the need for further research on whether vitamin D supplements can protect against the movement disorder, according to an editorial in the July 2010 issue of Archives of NeurologyThe author of the editorial is Marian Evatt, MD,

read more>>

NEW YORK -- The Michael J. Fox Foundation for Parkinson's Research today announced $1.1 million in total funding to six different projects aimed at validating potential therapeutic targets for Parkinson's diseaseTarget validation is an essential phase of drug development, yet a lack of funding fo

read more>>

SAN FRANCISCO, CA -- Scientists at the Gladstone Institute of Neurological Disease (GIND) and Stanford University have shown how key circuits in the brain control movementThe research, published in the journal Nature not only establishes the function of these circuits, but offers promise for treat

read more>>